These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31599359)

  • 1. Legacy Effect in the Treatment of Hypertension: Persistent Cardiovascular Protection after Conclusion of Randomized Clinical Trials in Hypertension.
    Gallo G; Battistoni A; Coluccia R; Tocci G; Volpe M
    Curr Hypertens Rep; 2019 Oct; 21(11):85. PubMed ID: 31599359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.
    Mann J; Julius S
    Blood Press; 1998 May; 7(3):176-83. PubMed ID: 9758088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What have we learned from the current trials?
    Abbott KC; Bakris GL
    Med Clin North Am; 2004 Jan; 88(1):189-207. PubMed ID: 14871059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event.
    Perez MI; Musini VM; Wright JM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006743. PubMed ID: 19821384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretics for cardiovascular prevention in the elderly.
    Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term perspectives of antihypertensive therapy. An introduction.
    Zanchetti A
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):2S-5S. PubMed ID: 8466721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
    Saiz LC; Gorricho J; Garjón J; Celaya MC; Muruzábal L; Malón MDM; Montoya R; López A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD010315. PubMed ID: 29020435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ASCOT trial: clarifying the role of ACE inhibition in the reduction of cardiovascular events in patients with hypertension.
    Meurin P
    Am J Cardiovasc Drugs; 2006; 6(5):327-34. PubMed ID: 17083267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus.
    Fuller J; Stevens LK; Chaturvedi N; Holloway JF
    Cochrane Database Syst Rev; 2007 Jul; (4):CD002188. PubMed ID: 17636699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.